Medipattern's Visualize:Vascular Begins Roll Out in the South Eastern United States

Attention: Business/Financial Editors 

The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI),
announced today that SonoCare, LLC ("SonoCare") has received
Visualize:Vascular(TM) and will begin offering the 3D visualization procedure to
patients through its 53 mobile sites serving communities in North and South
Carolina. SonoCare brings cutting edge mobile imaging technology directly to the
physician's office and direct to patients in residential settings. Their highly
qualified and experienced sonographers offer Ultrasound imaging services to
patients in the convenience and comfort of familiar surroundings. SonoCare is
dedicated to providing courteous, thorough, and compassionate patient care of
the highest quality with uncompromised results and outstanding service. SonoCare
is one of the few companies in the Carolina's that is accredited by the
Intersocietal Commission for the Accreditation of Echocardiography Laboratories
("ICAEL"). This ICAEL accreditation was achieved because of their commitment to
quality patient care.


"We are very pleased to be the first vascular imaging company to offer
Visualize:Vascular in the Southeastern United States," stated Mark Schubring,
Clinical Director of SonoCare. "Carotid artery disease ("CAD") is a major
concern in our communities. SonoCare performs a significant number of carotid
duplex exams and screenings each month to identify patients that may benefit
from additional medical attention. We believe that this 3D technology for
ultrasound will give us an edge for patients who are difficult to image." 


"SonoCare brings state of the art ultrasound imaging technology and certified
sonographers to the doctor's offices that they serve. Their outstanding American
College of Radiology ("ACR") accredited program ensures exceptional patient
care. Installation and training are expected to be completed by the end of this
quarter as each site is phased in," stated Jeff Collins, CEO The Medipattern
Corporation. "We continue to grow our installed base and scanning volume is
expected to continue to grow as we roll out our software throughout the
Southeastern United States. We are very pleased to work with SonoCare and
support their commitment to quality imaging procedures."


Upcoming Events

Annual Meeting - MHA  June 6 - 7, 2012  Brewster, MA

SVU/SVS Annual Conference  June 7 - 9, 2012  Baltimore, MD

About the Medipattern Corporation: 

Medipattern(R) is a pioneer in the development of imaging software solutions
that help medical practitioners to better understand lesions and critical
anatomy. Medipattern uses its Cadenza(TM) technology to process images, finding
the salient region of interest and presenting them in 2D and 3D formats that
enhance the reader's perception. For more information, please visit the
Company's website: www.medipattern.com.


Medipattern(R) is a registered trademark of The Medipattern Corporation.
Cadenza(TM) is a trademark of the Medipattern Corporation. SonoCine(R) is a
registered trademark of SonoCine, Inc.


Forward-looking statements 

This document contains forward-looking statements relating to Medipattern's
performance, operations, or business environment. These statements are based on
what we believe are reasonable assumptions given currently available information
and our understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements using words such
as "anticipates,'' "believes,'' "estimates,'' "expects,'' "plans,'' "intends,''
"potential'', and similar expressions. Forward-looking statements are not
guarantees of future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause actual outcomes
and results to differ materially from those expressed in forward-looking
statements. These factors include but are not limited to those set forth in the
Company's corporate filings, (posted at www.sedar.com). In addition, these
forward-looking statements relate to the date on which they are made. The
Company disclaims any intention or obligation to update or revise any
forward-looking statements for any reason. Readers should not rely on
forward-looking statements.